中文 | English
Return
Total: 53 , 1/6
Show Home Prev Next End page: GO
Author:(Mu-Zi LI)

1. Effects of metabolites of eicosapentaenoic acid on promoting transdifferentiation of pancreatic OL cells into pancreatic β cells

Chao-Feng XING ; Min-Yi TANG ; Qi-Hua XU ; Shuai WANG ; Zong-Meng ZHANG ; Zi-Jian ZHAO ; Yun-Pin MU ; Fang-Hong LI

Chinese Pharmacological Bulletin 2024;40(1):31-38

2. Expression, purification, and functional verification of recombinant human glycoprotein hormone beta 5/alpha 2 fusion protein in CHO-S cells

Ai-Jun QIAN ; Geng-Miao XIAO ; Zhuang LI ; Yun-Ping MU ; Zi-Jian ZHAO ; Fang-Hong LI ; Zhi-Cheng LIANG

Chinese Pharmacological Bulletin 2024;40(2):390-396

3.Protective Effect of Endogenous ω-3 Polyunsaturated Fatty Acid Against Cisplatin-Induced Myelosuppression

Qi-Hua XU ; Zong-Meng ZHANG ; Chao-Feng XING ; Han-Si CHEN ; Ke-Xin ZHENG ; Yun-Ping MU ; Zi-Jian ZHAO ; Fang-Hong LI

Journal of Experimental Hematology 2024;32(5):1601-1607

4.Clinical value of the MeltPro MTB assays in detection of drug-resistant tuberculosis in paraffin-embedded tissues.

Jia Lu CHE ; Zi Chen LIU ; Kun LI ; Wei Li DU ; Dan ZHAO ; Jing MU ; Yu Jie DONG ; Nan Ying CHE

Chinese Journal of Pathology 2023;52(5):466-471

5. Effect of FKBP38 protein on endometrial precancerous lesions and mechanism

Yun-Jing YAN ; Yun-Ping MU ; Shuai WANG ; Zi-Jian ZHAO ; Fang-Hong LI

Chinese Pharmacological Bulletin 2023;39(7):1320-1324

6. Effect of menthol, a transient receptor potential melastatin-8 channel activator, on pulmonary arterial hypertensive rats

Hao-Heng GTU ; Zhuang LI ; Jian-Qin YANG ; Wen-Bin FENG ; Xiao-Qing LIU ; Zi-Jian ZHAO ; Yun-Ping MU ; Fang-Hong LI ; Bin LI

Chinese Pharmacological Bulletin 2023;39(4):700-706

7. Expression, purification and functional verification of recombinant human α-galactosidase A in suspension CHO-S

Mu-Lan DENG ; Hong-Yu ZHOU ; Ke-Xin ZHENG ; Zhao-Yang LI ; Wan-Yi GUO ; Yan-Ping WANG ; Zhi-Cheng LIANG ; Fang-Hong LI ; Yun-Ping MU ; Zi-Jian ZHAO

Chinese Pharmacological Bulletin 2023;39(4):774-781

8. Effect of a novel phosphodiesterase type 5 inhibitor, CPD1, on carbon tetrachloride-induced liver fibrosis in mice

Wen-Bin FENG ; Jian-Qin YANG ; Xin-Hui CHEN ; Zhong-Lian XIE ; Ying-Ying ZHANG ; Ying-Xi CHEN ; Zi-Jian ZHAO ; Yun-Ping MU ; Fang-Hong LI

Chinese Pharmacological Bulletin 2023;39(3):470-476

9. Effect of a novel phosphodiesterase type 5 inhibitor,CPD1,on unilateral renal interstitial fibrosis caused by ureteric obstruction in mice

Ao-Lu LIU ; Wen-Bin FENG ; Bin LI ; Xin-Hui CHEN ; Si-Rong LI ; Zi-Jian ZHAO ; Yun-Ping MU ; Fang-Hong LI ; Qian REN

Chinese Pharmacological Bulletin 2023;39(1):147-152

10. Effect of a novel phosphodiesterase type 5 inhibitor, CPD1, on paraquat-induced lung fibrosis in rats

Jie GAO ; Jian WU ; Jie GAO ; Jing ZHANG ; Jian WU ; Jian-Qin YANG ; Hao-Heng QIU ; Zi-Jian ZHAO ; Fang-Hong LI ; Yun-Ping MU

Chinese Pharmacological Bulletin 2023;39(6):1136-1142

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 53 , 1/6 Show Home Prev Next End page: GO